Merck Still Vows To Fight Vioxx Cases One Suit At A Time

Law360, New York (October 20, 2006, 12:00 AM EDT) -- Even with nearly 24,000 Vioxx-related lawsuits filed around the country, Merck & Co. is still reportedly looking to thwart any consolidation of cases.

Merck is concerned about the potential strategies involved in multiple case trials, said the pharmaceutical company’s chief executive, Richard T. Clark, according to Dow Jones. He added that consolidated trials with different states, risk factors, preexisting conditions and other issues are extremely complex for a jury.

“We continue to work on convincing the judge that may not be an appropriate way to go,”...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.